Eric Jamois

Q: What is Eric Jamois email address?

Email Eric Jamois at eric@simulations-plus.com. This email is the most updated Eric Jamois email found in 2026.

Q: How to contact Eric Jamois?

To contact Eric Jamois send an email to eric@simulations-plus.com. If you want to call Eric Jamois try calling on +17609758565. (updated on October 29, 2024)

Business Development Director at Simulations Plus, Inc. | Oak Ridge, Tennessee, United States

About Eric Jamois

As the Business Development Director at Simulations Plus, Inc., Eric Jamois plays a pivotal role in advancing the company's mission to enhance drug discovery and development through innovative modeling and simulation solutions. With a strong focus on ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) and pharmacokinetics (PK), Eric leads strategic initiatives that drive the adoption of the ADMET Predictor™ and the comprehensive ADMET Cheminformatics suite. His expertise in computational chemistry and biopharmaceuticals enables him to effectively engage with key accounts, fostering long-term partnerships that are essential for the growth of Simulations Plus.

Eric's responsibilities extend beyond business development; he is instrumental in forging strategic alliances that enhance the company's competitive edge in the life sciences sector. By leveraging his extensive background in R&D and drug development, he provides scientific marketing support that articulates the value of Simulations Plus's offerings to potential clients. His ability to translate complex scientific concepts into actionable insights is key to positioning the company as a leader in the industry.

Under Eric's leadership, Simulations Plus has successfully navigated the evolving landscape of drug development, ensuring that clients have access to data-driven methodologies that streamline the research process from early discovery through clinical trials and post-approval. His commitment to innovation and excellence not only drives business growth but also contributes to the advancement of therapeutic solutions that improve patient outcomes. With a keen understanding of the challenges faced by biopharmaceutical companies, Eric continues to be a vital asset in the pursuit of more efficient and effective drug development processes.

Eric Jamois Work